John Divine

John Divine

John Divine is currently an investing reporter at U.S. News & World Report, and was previously an assistant editor at InvestorPlace.com. He has worked variously in the fields of commercial real estate, money management and digital media, working as a financial journalist for most of his professional career.

John has also been a regular contributor to The Motley Fool, and his work also has appeared on AOL DailyFinance.

In 2013, he shortened his bucket list when he saw Warren Buffett live and in the flesh while covering the Berkshire Hathaway Annual Shareholders’ Meeting.

A proud North Carolinian and graduate of Appalachian State University, John majored in Finance & Banking. He enjoys basketball, reading, writing and food. He does not care for the Oxford comma, and he does not require the food he enjoys to be nutritious.

Recent Articles

WOW … Alphabet Inc Stock Has Some Losing Bets (GOOG, GOOGL)

Alphabet (GOOG) stock has been hot recently ... but its non-core businesses has had little to do with it.

Sell Tesla Stock Before It Stalls Out Completely! (TSLA)

Tesla's comically awful record of delays is catching up to TSLA stock, and analysts are tripping over themselves to downgrade shares

Oppenheimer: Fitbit Inc (FIT) Stock Has 50% Upside – Is It a Buy?

The Fitbit (FIT) stock price refuses to reflect any of the bullish factors that can ignite a rally in shares ... including adoring analysts.

GPRO Stock: Expect MISERABLE Q4 From GoPro Inc

The GoPro (GPRO) stock price has been investors' worst nightmare in recent months. Q4 earnings will be bad; be careful before bottom fishing.

Snapchat Now Battling Facebook Inc (FB) and Twitter Inc (TWTR) in Sports

"Snapchat Sports?" With Facebook (FB) and Twitter (TWTR) both vying to encourage live sports fans to engage, Snapchat throws its hat in the ring.

Chipotle Mexican Grill, Inc. (CMG): Still SUPER Risky Before Earnings

Chipotle (CMG) stock has had a rough six-month stretch. So is now the time for long-term investors to swoop in and buy? Absolutely not.

Gilead Sciences, Inc – Selloff Makes GILD Stock a Serious Bargain

The Gilead (GILD) stock price continues to take a beating after Merck gained FDA approval for a rival hep-C treatment. So what? Gilead's still a buy.

Microsoft Corporation (MSFT): CEO Satya Nadella Is the Anti-Ballmer

MSFT stock is in good hands as CEO Satya Nadella successfully navigates a path to a cloud-based future. Ballmer's absence is sweet.

The 10 Best Healthcare Stocks to Buy Now

This list of the 10 best healthcare stocks to buy now includes extremely well-capitalized companies paying extraordinary dividends ... and trading for cheap.

PayPal Holdings Inc: PYPL Soars, eBay Crashes on Earnings

The PayPal (PYPL) stock price is soaring on Thursday after an exemplary Q4 earnings report. Meanwhile, eBay is tanking -- good thing they split!